GADD34 Protein (AA 433-636) (His tag)
-
- Target See all GADD34 (PPP1R15A) Proteins
- GADD34 (PPP1R15A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 15A (PPP1R15A))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 433-636
-
Origin
- Mouse
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This GADD34 protein is labelled with His tag.
- Application
- Western Blotting (WB), Positive Control (PC), Immunogen (Imm), SDS-PAGE (SDS)
- Sequence
- Pro433-Thr636
- Characteristics
- Recombinant Protein Phosphatase 1, Regulatory Subunit 15A (PPP1R15A), Prokaryotic expression, Pro433-Thr636, N-terminal His Tag
- Purity
- > 95 %
- Top Product
- Discover our top product PPP1R15A Protein
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- GADD34 (PPP1R15A) (Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 15A (PPP1R15A))
- Alternative Name
- Protein Phosphatase 1, Regulatory Subunit 15A (PPP1R15A Products)
- Synonyms
- 9630030H21 Protein, Gadd34 Protein, Myd116 Protein, GADD34 Protein, Peg-3 Protein, RGD1624209 Protein, protein phosphatase 1 regulatory subunit 15A Protein, protein phosphatase 1, regulatory (inhibitor) subunit 15A Protein, protein phosphatase 1, regulatory subunit 15A Protein, PPP1R15A Protein, Ppp1r15a Protein
- Background
- PPP1-R15A, PPP1R15-A, PPP1-R15-A, GADD34, Growth Arrest And DNA-Damage-Inducible 34, Myeloid differentiation primary response protein MyD116 homolog
- UniProt
- P17564
- Pathways
- ER-Nucleus Signaling, Unfolded Protein Response
-